Is there still a possibility that science will conclude XMRV is indeed a human gammaretrovirus and that it may play a role in chronic fatigue syndrome (ME/CFS)? Yes, according to “Nevada Newsmakers” TV Host Sam Shad’s interview with Whittemore-Peterson Institute co-founder Annette Whittemore, dated Monday, June 20, 2011.
The interview, offered HERE http://www.nevadanewsmakers.com/video/default.asp?showID=1298 (expect about 3 minutes of preliminary ads), seems encouraging for patients with ME/CFS and other neuro-immune illnesses who will be seeking help at the Reno-based WPI clinic – for a number of reasons.
A few of the issues Annette discusses include:
• Their surprise that, though scientific debate is necessary and to be expected, a procession of negative reports have been published “using over and over the same methods and materials” which she says have been different than the WPI methods and materials used in the original positive Lombardi, et al. report published in 2009.
• What the WPI researchers are studying now relating to ME/CFS pathogenesis, diagnosis, and treatment. Including continuing work on both “deep-sequencing” the entire length of the XMRV genome, which nobody has yet done; on human antibodies in ME/CFS samples; and more.
• The XMRV-related, NIH-sponsored study of ME/CFS and healthy donor blood that Columbia University “virus hunter” Ian Lipkin, MD is engaged in – and his upcoming visit to the WPI on Friday, June 24 to give a presentation and consult privately with WPI researchers on their work.
• The researchers who have come to the WPI or who have met with traveling WPI researchers to learn and share their methods & materials. Expect them to present the results of their replicative studies over time, she says.
• The promising fact that blood supply managers in many countries who are banning or advising against ME/CFS blood donations are acknowledging “that ME/CFS patients are very very ill, and the possibility of an infectious origin.”
• The health of Annette’s daughter Andrea, an ME/CFS patient, who she says is doing better… and more.